Scott M. Hammer

Publications

3 shown

A Controlled Trial of Two Nucleoside Analogues plus Indinavir in Persons with Human Immunodeficiency Virus Infection and CD4 Cell Counts of 200 per Cubic Millimeter or Less

Scott M. Hammer , Kathleen Squires , Michael D. Hughes +13 more

Treatment with indinavir, zidovudine, and lamivudine as compared with zidovudine and lamivudine alone significantly slows the progression of HIV-1 disease in patients with 200 C...

1997 New England Journal of Medicine 2664 citations

A Trial Comparing Nucleoside Monotherapy with Combination Therapy in HIV-Infected Adults with CD4 Cell Counts from 200 to 500 per Cubic Millimeter

Scott M. Hammer , David Katzenstein , Michael D. Hughes +9 more

Treatment with zidovudine plus didanosine, zidovudine plus zalcitabine, or didanosine alone slows the progression of HIV disease and is superior to treatment with zidovudine alo...

1996 New England Journal of Medicine 1080 citations

The Relation of Virologic and Immunologic Markers to Clinical Outcomes after Nucleoside Therapy in HIV-Infected Adults with 200 to 500 CD4 Cells per Cubic Millimeter

David Katzenstein , Scott M. Hammer , Michael D. Hughes +9 more

Both the risk of the progression of HIV disease and the efficacy of antiretroviral therapy are strongly associated with the plasma level of HIV RNA and with the viral phenotype....

1996 New England Journal of Medicine 483 citations

Researcher Info

h-index: 3
Publications: 3
Citations: 4,227
Institution: Harvard University

External Links

Google Scholar

Impact Metrics

h-index 3

h-index: Number of publications with at least h citations each.

Publications

A Controlled Trial of Two Nucleoside Analogues plus Indinavir in Persons with Human Immunodeficiency Virus Infection and CD4 Cell Counts of 200 per Cubic Millimeter or Less

A Trial Comparing Nucleoside Monotherapy with Combination Therapy in HIV-Infected Adults with CD4 Cell Counts from 200 to 500 per Cubic Millimeter

The Relation of Virologic and Immunologic Markers to Clinical Outcomes after Nucleoside Therapy in HIV-Infected Adults with 200 to 500 CD4 Cells per Cubic Millimeter

Frequent Co-Authors

Kathleen Squires

Michael D. Hughes

Janet M. Grimes

Lisa M. Demeter

Judith S. Currier

Joseph J. Eron

Researcher Info

External Links

Impact Metrics